Related Experiment Video

Updated: Aug 10, 2026

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Delivery of molecular and cellular medicine to solid tumors

R K Jain1

  • 1Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. jain@steele.mgh.harvard.edu

Advanced Drug Delivery Reviews
|March 22, 2001
PubMed

Insights

Researchers are analyzing how therapeutic molecules reach cancer cells within tumors. Understanding these physiological barriers is key to developing new cancer detection and treatment strategies.

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Cancer Biology

Background:

  • Solid tumors present significant physiological barriers that impede the delivery of therapeutic agents.
  • Effective cancer treatment requires overcoming these barriers to ensure drug or cell penetration to cancer cells.

Purpose of the Study:

  • To experimentally and theoretically analyze the steps involved in therapeutic molecule and cell transport into tumors.
  • To integrate findings into a unified theoretical framework for understanding tumor physiology.
  • To develop novel strategies for improved cancer detection and treatment by exploiting or overcoming tumor barriers.

Main Methods:

  • Experimental analysis of molecular and cellular transport within tumor microenvironments.
  • Theoretical modeling to understand the dynamics of interstitial transport and vessel wall penetration.
  • Integration of experimental and theoretical data into a comprehensive framework.

Main Results:

  • Identification of specific physiological barriers hindering therapeutic delivery in solid tumors.
  • Development of a unified theoretical model elucidating transport dynamics.
  • Insights into strategies for enhancing drug and cell penetration into tumors.

Conclusions:

  • A deeper understanding of tumor physiological barriers is achieved through integrated analysis.
  • Novel strategies to overcome or exploit these barriers can improve cancer therapy.
  • This research paradigm advances cancer detection and treatment methodologies.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...